Target specificity of human RNA-induced silencing complex
人RNA诱导的沉默复合物的靶标特异性
基本信息
- 批准号:9368173
- 负责人:
- 金额:$ 29.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alternative SplicingBase PairingBindingBinding SitesBiochemicalBiological AssayC-terminalCalcium ChannelCellsCerebellar AtaxiaCharacteristicsChemicalsCollaborationsComplexCrystallizationDevelopmentDiseaseDissociationElementsEukaryotic CellGene ExpressionGene SilencingGenetic TranscriptionGoalsGuide RNAHumanInternal Ribosome Entry SiteLengthLobeMasksMediatingMessenger RNAMethodsMicroRNAsModelingMolecularN-terminalNucleic Acid BindingNucleic AcidsOutcome StudyParentsPatternPhysiologicalPlayProtein CProteinsRNARNA BindingRNA InterferenceRNA analysisRNA-Binding ProteinsRNA-Induced Silencing ComplexRegulationRibonucleoproteinsRoentgen RaysRoleSaccharomycetalesShapesSpecificityStructureTestingTranscriptTranscription InitiationTranslational RepressionTranslationsUntranslated RNAVariantX-Ray Crystallographybasebioprocesschromatin remodelingdesignexperimental studyinnovationmutantnervous system disordernovel therapeuticspreventscaffoldvoltage
项目摘要
PROJECT SUMMARY
In eukaryotic cells, gene expression is controlled at multiple different layers. One of them is post-
transcriptional gene silencing where microRNAs (miRNAs) bind target mRNAs in a sequence complementary
manner and cause translational repression and/or deadenylation. In humans, miRNAs are loaded onto one of
four Argonaute proteins (AGOs), forming a ribonucleoprotein complex terms `RNA-induced silencing complex
(RISC)'. The target specificity of the RISC has been defined solely by the base complementarity between the
miRNA (guide) and target strands. The loaded guide strand occupies part of the nucleic acid-binding
channel between the AGO N-terminal and C-terminal lobes, while the remaining space serves as the
composite target-binding channel. In this study, we hypothesize that the target specificity of the RISC is
defined by the structure of the composite channel rather than just base complementarity, and thus that four
human AGOs possess different target specificities due to their unique local structures. To validate this
hypothesis, we will pursue the following specific aims. In Aim 1, cleavage assay and chemical probing will be
used to determine how differently target strands are recognized in the presence and absence of the N-
terminal lobe. In Aim 2, X-ray crystallography will be used to solve the structure of human AGO3-RISC. This
structure, along with the previously determined ones, will enable us to identify local structures making their
target-binding channels different from each other. RNA bind-n-seq experiments using wild type and its
mutant lacking the identified unique local structure(s) will determine the target specificities conferred by the
characteristic target-binding channel. In Aim 3, filter-binding assays and chemical probing will be used to
elucidate the molecular mechanism by which a miRNA, miR-3191-5p, activates only AGO4 for binding to the
internal ribosome entry site (IRES) of CACNA1A mRNA, and blocks its IRES-driven translation to prevent the
neurological disease. Outcomes from this study will provide a new concept on the target specificity of the
RISC, which is significant because beyond canonical gene silencing, many different cellular bioprocesses are
regulated by miRNAs.
项目摘要
在真核细胞中,基因表达在多个不同的层中受到控制。其中之一是
转录基因沉默,其中microRNA(miRNA)以序列互补结合靶标mRNA
方式并引起翻译抑制和/或去甲基化。在人类中,miRNA被加载到一个
四种Argonaute蛋白(AGO),形成核糖核蛋白复合物术语`RNA诱导的沉默复合物
(RISC)'。 RISC的目标特异性仅由基本互补性来定义
miRNA(指南)和目标链。加载的导链占据了核酸结合的一部分
AGO N末端和C末端裂片之间的通道,其余空间用作
复合目标结合通道。在这项研究中,我们假设RISC的目标特异性是
由复合通道的结构定义,而不仅仅是基础互补性,从而四个
由于其独特的局部结构,人类AGO具有不同的目标特异性。验证这一点
假设,我们将追求以下特定目标。在AIM 1中,切割测定和化学探测将是
用于确定在存在和不存在N-的情况下识别目标链的不同
终端叶。在AIM 2中,X射线晶体学将用于解决人类AGO3-RISC的结构。这
结构以及先前确定的结构将使我们能够确定局部结构
目标结合通道彼此不同。 RNA结合-N-Seq实验使用野生型及其
缺乏确定的独特局部结构的突变体将确定赋予的目标特异性
特征目标结合通道。在AIM 3中,将使用过滤器结合测定和化学探测
阐明miRNA miRNA,miR-3191-5p仅激活AGO4的分子机制,以与
CACNA1A mRNA的内部核糖体进入位点(IRES),并阻止其IRES驱动的翻译以防止
神经疾病。这项研究的结果将提供有关目标特异性的新概念
RISC很重要,因为超出规范基因沉默之外,许多不同的细胞生物处理是
由miRNA调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kotaro Nakanishi其他文献
Kotaro Nakanishi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kotaro Nakanishi', 18)}}的其他基金
Tiny RNAs as new potential biomarkers for gammaherpesvirus-driven neurological and central nervous system diseases
微小RNA作为伽马疱疹病毒驱动的神经和中枢神经系统疾病的新潜在生物标志物
- 批准号:
10727761 - 财政年份:2023
- 资助金额:
$ 29.87万 - 项目类别:
Structural and molecular basis for cityRNA (cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3
AGO3 指导的 cityRNA(切割诱导微小 RNA)切割 RNA 的结构和分子基础
- 批准号:
10582158 - 财政年份:2020
- 资助金额:
$ 29.87万 - 项目类别:
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3
AGO3 指导的 cityRNA(切割诱导微小 RNA)切割 RNA 的结构和分子基础
- 批准号:
10034828 - 财政年份:2020
- 资助金额:
$ 29.87万 - 项目类别:
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3
AGO3 指导的 cityRNA(切割诱导微小 RNA)切割 RNA 的结构和分子基础
- 批准号:
10426117 - 财政年份:2020
- 资助金额:
$ 29.87万 - 项目类别:
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3
AGO3 指导的 cityRNA(切割诱导微小 RNA)切割 RNA 的结构和分子基础
- 批准号:
10213789 - 财政年份:2020
- 资助金额:
$ 29.87万 - 项目类别:
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3
AGO3 指导的 cityRNA(切割诱导微小 RNA)切割 RNA 的结构和分子基础
- 批准号:
10647680 - 财政年份:2020
- 资助金额:
$ 29.87万 - 项目类别:
Target specificity of human RNA-induced silencing complex
人RNA诱导的沉默复合物的靶标特异性
- 批准号:
9980454 - 财政年份:2017
- 资助金额:
$ 29.87万 - 项目类别:
Target specificity of human RNA-induced silencing complex
人RNA诱导的沉默复合物的靶标特异性
- 批准号:
10522487 - 财政年份:2017
- 资助金额:
$ 29.87万 - 项目类别:
Target specificity of human RNA-induced silencing complex
人RNA诱导的沉默复合物的靶标特异性
- 批准号:
10237195 - 财政年份:2017
- 资助金额:
$ 29.87万 - 项目类别:
Target specificity of human RNA-induced silencing complex
人RNA诱导的沉默复合物的靶标特异性
- 批准号:
10687141 - 财政年份:2017
- 资助金额:
$ 29.87万 - 项目类别:
相似国自然基金
通过分子链“配对混合”调控立构复合聚乳酸熔体稳定性的基础研究
- 批准号:52373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
父本选配对尾叶桉F1杂种优势的遗传基础研究
- 批准号:31600545
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Decoding global RNP topologies in splicing regulation
解码拼接调节中的全局 RNP 拓扑
- 批准号:
10636541 - 财政年份:2023
- 资助金额:
$ 29.87万 - 项目类别:
The role of U1 snRNP proteins in snRNP biogenesis and gene expression regulation
U1 snRNP 蛋白在 snRNP 生物发生和基因表达调控中的作用
- 批准号:
10796664 - 财政年份:2023
- 资助金额:
$ 29.87万 - 项目类别:
Establishing and reversing the functional consequences of Titin truncation mutations
建立并逆转肌联蛋白截断突变的功能后果
- 批准号:
10510011 - 财政年份:2022
- 资助金额:
$ 29.87万 - 项目类别:
Establishing and reversing the functional consequences of Titin truncation mutations
建立并逆转肌联蛋白截断突变的功能后果
- 批准号:
10640157 - 财政年份:2022
- 资助金额:
$ 29.87万 - 项目类别:
Quantitative and Predictive Analysis of 5' Splice Site Recognition by U1 snRNP using Massively Parallel Arrays
使用大规模并行阵列对 U1 snRNP 5 剪接位点识别进行定量和预测分析
- 批准号:
10460136 - 财政年份:2021
- 资助金额:
$ 29.87万 - 项目类别: